Filing Details
- Accession Number:
- 0001209191-21-009822
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-11 17:59:26
- Reporting Period:
- 2021-02-08
- Accepted Time:
- 2021-02-11 17:59:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1020214 | Cerus Corp | CERS | Surgical & Medical Instruments & Apparatus (3841) | 680262011 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1564252 | Chrystal Menard | C/O Cerus Corporation 1220 Concord Ave Suite 600 Concord CA 94520 | Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-08 | 4,167 | $4.33 | 52,752 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-08 | 4,167 | $8.00 | 48,585 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-02-08 | 3,958 | $4.32 | 52,543 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-08 | 3,958 | $8.00 | 48,585 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (Right to Buy) | Disposition | 2021-02-08 | 4,167 | $0.00 | 4,167 | $4.33 |
| Common Stock | Option (Right to Buy) | Disposition | 2021-02-08 | 3,958 | $0.00 | 3,958 | $4.32 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 6,250 | 2027-02-28 | No | 4 | M | Direct | |
| 29,688 | 2028-02-28 | No | 4 | M | Direct |
Footnotes
- This transaction was executed pursuant to a 10b5-1 plan.
- One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter.
- Not applicable.
Billionaire Hedge Funds
